Svelte Medical Systems, a New Providence, NJ-based developer of balloon expandable stents, raised $5m in funding.
The West Health Investment Fund made the investment, which is in addition to a recent $22m round raised from CNF Investments and New Science Ventures (read here).
The company will use the funds to accelerate regulatory approval processes in the US and Japan, enhance operational efficiencies and augment commercial preparation activities of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) and Rapid-Exchange (RX) platforms.
Founded in 2007 by Robert Fischell, ScD, David Fischell, PhD and Tim Fischell, MD, Svelte Medical Systems is currently led by Jack Darby, President and CEO.
FinSMEs
10/03/2014